6 insiders reported 11 Form 4 transactions for Allarity Therapeutics, Inc. (ALLR) over the past 18 months (most recent 2026-05-14). Recent activity: Jensen Thomas (CEO) Buy 200,000 shares, Hoeiland Jesper (Director) Buy 25,000 shares, McLaughlin Gerald W. (Director) Buy 45,000 shares, Ervin Jeffrey S (CFO) Buy 150,000 shares, Graff Jeremy R. (See Remarks) Buy 133,333 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Jensen Thomas | CEO | Buy | 200,000 | $0 |
| 2026-05-11 | Hoeiland Jesper | Director | Buy | 25,000 | $0 |
| 2026-05-07 | McLaughlin Gerald W. | Director | Buy | 45,000 | $0 |
| 2026-04-30 | Ervin Jeffrey S | CFO | Buy | 150,000 | $0 |
| 2026-04-30 | Graff Jeremy R. | See Remarks | Buy | 133,333 | $0 |
| 2026-01-16 | Graff Jeremy R. | See Remarks | Buy | 133,333 | $0 |
| 2025-10-02 | Graff Jeremy R. | See Remarks | Buy | 39,494 | $0 |
| 2025-10-02 | Graff Jeremy R. | See Remarks | Sell | 14,613 | $23,089 |
| 2025-01-24 | Graff Jeremy R. | CDO | Buy | 144,441 | $0 |
| 2025-01-24 | Jensen Thomas | CEO | Buy | 396,734 | $0 |
| 2025-01-24 | Epshinsky Alexander | CFO | Buy | 29,496 | $0 |
Source: SEC Form 4 filings · as of 2026-05-14
